window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.2.1\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.2.1\/svg\/","svgExt":".svg","source":{"concatemoji":"http:\/\/www.write2market.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.7.5"}}; !function(a,b,c){function d(a){var b,c,d,e,f=String.fromCharCode;if(!k||!k.fillText)return!1;switch(k.clearRect(0,0,j.width,j.height),k.textBaseline="top",k.font="600 32px Arial",a){case"flag":return k.fillText(f(55356,56826,55356,56819),0,0),!(j.toDataURL().length<3e3)&&(k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57331,65039,8205,55356,57096),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57331,55356,57096),0,0),c=j.toDataURL(),b!==c);case"emoji4":return k.fillText(f(55357,56425,55356,57341,8205,55357,56507),0,0),d=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55357,56425,55356,57341,55357,56507),0,0),e=j.toDataURL(),d!==e}return!1}function e(a){var c=b.createElement("script");c.src=a,c.defer=c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var f,g,h,i,j=b.createElement("canvas"),k=j.getContext&&j.getContext("2d");for(i=Array("flag","emoji4"),c.supports={everything:!0,everythingExceptFlag:!0},h=0;h

Write2Market Healthcare Practice Expands Again with the Addition of Isoray, Inc. (NYSE: ISR)

Write2Market is pleased to announce the addition of Isoray, Inc. (NYSE: ISR) to its roster of industry leading healthcare clients. Through metrics-based marketing tactics and tools including lead-generating content, SEO, earned media and industry speaking opportunities, Write2Market intends to enhance Isoray’s market position as a champion in the world of brachytherapy and targeted cancer treatment. Initially, W2M will support Isoray’s growth by focusing on the company’s clinician pioneer stories and growing base of Cesium-131 outcomes and implementing a robust marketing program surrounding the 2017 American Brachytherapy Society’s Annual Conference.

Isoray joins W2M with momentum in tow including the recent release of groundbreaking data for their Cesium-131 Brachytherapy, the realignment of their management team and a new web presence.

About Isoray

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options for cancer treatment throughout the body. Isoray’s Cesium-131 brachytherapy introduces titanium encapsulated doses or seeds of Cesium-131 radiation directly into cancerous tumors. Its higher energy and shorter half life compared to Iodine-125 and Palladium-103 helps bring patients dealing with prostate, brain, gynecological, lung, head, and neck cancers to remission while decreasing the debilitating side effects that often accompany other cancer treatments.

More than 10,000 patients, mostly prostate cancer patients, have been treated with Isoray’s Cesium-131 brachytherapy. At five years, 96% of men with low risk [prostate cancer], 92.7 of men with intermediate risk disease and 82.9% of men with high risk disease showed no evidence of disease progression.

About Write2Market’s Healthcare Practice

“This has been an outstanding year for the Write2Market healthcare practice, especially in terms of growth,” says Paul Snyder, Vice President of Healthcare for Write2Market. “Our success validates the market for effective analytics and results driven content marketing for growth stage healthcare companies. We thank the Isoray team, particularly VP of Marketing Mike Krachon and Rita Mucavele, for giving us the opportunity to demonstrate our capabilities on their behalf.”

The Write2Market Healthcare Practiced added four new clients to the roster this year including Dune Medical Devices- the makers of MarginProbe, The Global Center for Medical Innovation (GCMI), Health Connect South and Isoray, Inc. The agency will support medication management and specialty pharmacy fulfillment firm Curant Health for a fourth straight year, industry leading preclinical CRO T3 Labs for a third straight year and expand its relationship with hospital product global sourcing experts ASP Global. The Southeastern Medical Device Association (SEMDA) has also engaged W2M for a third straight year to support awareness and audience development for its flagship annual conference, April 26-27, 2017 in Atlanta.

 

“In addition to high-level corporate message creation, Write2Market ensures that audiences Curant Health seeks to connect with and influence know about the measurable effects and outcomes of Curant’s capabilities and programs.” – Kristin Lindsey, Senior Director of Marketing for Curant Health

 

“I love Write2Market’s ability to extract the right and relevant information from our sponsors that made our stories resonate with our industry colleagues.” – Deepal Panchal, Program Director for T3 Labs

 

“It is immensely satisfying to know that the Write2Market Healthcare Practice and team has been able to demonstrate value on a daily basis for our healthcare clients: positioning them as industry leaders while keeping a sharp eye on the value-based metrics and outcomes that move the meter as they each navigate the industry’s shift to value-based care,” Snyder says. “I am entirely confident this was a key factor in causing Isoray to select Write2Market in support of their healthcare content marketing and public relations program.”

Contact

Emily Simpson

emily.simpson@write2market.com
Follow Write2Market on LinkedIn and Twitter.

Write2Market will accompany Isoray during the American Brachytherapy Society Annual Meeting where they will host a symposium titled “Brachytherapy in the era of value-based medicine: are your top referrers hiding in plain sight?” Our VP of Healthcare, Paul Snyder will be apart of the panel- providing an in depth look at how clinicians can build a brand and then communicate it. Are you attending ABS 2017? Connect with us! Contact Paul Snyder to arrange an on-site meeting in Boston.